Loading clinical trials...
Loading clinical trials...
To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Meridian Bioscience, Inc.
NCT06439342 · Cytomegalovirus (CMV)
NCT07235683 · CMV, Lung Transplant Recipient
NCT07014319 · Cytomegalovirus (CMV)
NCT06555432 · Cytomegalovirus (CMV)
NCT07096453 · Kidney Transplant; Complications, CMV
University of Alabama at Birmingham
Birmingham, Alabama
University of Utah
Salt Lake City, Utah
The Prince of Wales Hospital
Randwick, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions